What is UBS's price target for CMA?

UBS's latest stated price target for Comerica Incorporated (CMA) is $59, from its action on Apr 10, 2025.

What is UBS's rating on CMA?

UBS rates CMA Neutral, a neutral rating, as of Apr 10, 2025.

When did UBS last change its view on CMA?

On Apr 10, 2025, UBS upgrades to Neutral from Sell, price target $59.

UBS CMA price target and rating history

UBS rates Comerica Incorporated (CMA) Neutral with a $59 price target, as of its latest action on Apr 10, 2025. It has published 3 rating actions on CMA since March 2023, including 1 upgrade and 0 downgrades.

Current rating: Neutral
Price target: $59
Median target, all firms: Too few
Actions on CMA: 3

UBS price target on CMA

UBS price target on CMA, each point a stated target, March 2023 to April 2025.

Every UBS rating on CMA

Apr 10, 2025
UpgradeUBS upgrades to Neutral from Sell, price target $59
Dec 17, 2024
ResumeUBS resumes coverage at Sell
Mar 15, 2023
InitiateUBS starts coverage at Buy, price target $68

Questions about UBS and CMA

What is UBS's price target for CMA?: UBS's latest stated price target for Comerica Incorporated (CMA) is $59, from its action on Apr 10, 2025.
What is UBS's rating on CMA?: UBS rates CMA Neutral, a neutral rating, as of Apr 10, 2025.
When did UBS last change its view on CMA?: On Apr 10, 2025, UBS upgrades to Neutral from Sell, price target $59.

More CMA rating histories

All UBS ratings CMA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.